(Q61914897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

title

Recombinant human erythropoietin treatment improves platelet function in uremic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

Joan Carles Reverter Calatayud

15 September 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

author name string

A Cases

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

A Ordinas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

J Lopez-Pedret

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

L Revert

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

R Castillo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

language of work or name

English

0 references

publication date

1 September 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

668-672

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405344%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1992.333

15 September 2019

exact match

0 references

cites work

Bleeding in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Bleeding time in Uremia: A useful test to assess clinical bleeding

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Treatment of renal anemia with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Clinical Trial of a New Bleeding-time Device

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Recombinant human erythropoietin shortens the uraemic bleeding time without causing intravascular haemostatic activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Platelet interaction with subendothelium in a perfusion system: Physical role of red blood cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021

Erythropoietin and spontaneous platelet aggregation in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.333

7 January 2021